United States Therapeutic Vaccines Market Report 2017

February 2017 | 101 pages | ID: U592D5B5424EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Therapeutic Vaccines

Revenue, means the sales value of Therapeutic Vaccines

This report studies sales (consumption) of Therapeutic Vaccines in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Northwest Biotherapeutics
• Antigenics
• Vaccinogen?
• CIMAB S.A.
• Dendreon
• Corixa
• AVAX

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Therapeutic Vaccines in each application, can be divided into

• Application 1
• Application 2

Contents

United States Therapeutic Vaccines Market Report 2017

1 THERAPEUTIC VACCINES OVERVIEW

1.1 Product Overview and Scope of Therapeutic Vaccines
1.2 Classification of Therapeutic Vaccines
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Therapeutic Vaccines
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Therapeutic Vaccines (2012-2022)
  1.4.1 United States Therapeutic Vaccines Sales and Growth Rate (2012-2022)
  1.4.2 United States Therapeutic Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES THERAPEUTIC VACCINES COMPETITION BY MANUFACTURERS

2.1 United States Therapeutic Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Therapeutic Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Therapeutic Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Therapeutic Vaccines Market Competitive Situation and Trends
  2.4.1 Therapeutic Vaccines Market Concentration Rate
  2.4.2 Therapeutic Vaccines Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES THERAPEUTIC VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Therapeutic Vaccines Sales and Market Share by States (2012-2017)
3.2 United States Therapeutic Vaccines Revenue and Market Share by States (2012-2017)
3.3 United States Therapeutic Vaccines Price by States (2012-2017)

4 UNITED STATES THERAPEUTIC VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Therapeutic Vaccines Sales and Market Share by Type (2012-2017)
4.2 United States Therapeutic Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Therapeutic Vaccines Price by Type (2012-2017)
4.4 United States Therapeutic Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES THERAPEUTIC VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Therapeutic Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Therapeutic Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES THERAPEUTIC VACCINES MANUFACTURERS PROFILES/ANALYSIS

6.1 Northwest Biotherapeutics
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Therapeutic Vaccines Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Northwest Biotherapeutics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Antigenics
  6.2.2 Therapeutic Vaccines Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Antigenics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Vaccinogen?
  6.3.2 Therapeutic Vaccines Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Vaccinogen? Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 CIMAB S.A.
  6.4.2 Therapeutic Vaccines Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 CIMAB S.A. Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Dendreon
  6.5.2 Therapeutic Vaccines Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Dendreon Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Corixa
  6.6.2 Therapeutic Vaccines Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Corixa Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 AVAX
  6.7.2 Therapeutic Vaccines Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AVAX Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 THERAPEUTIC VACCINES MANUFACTURING COST ANALYSIS

7.1 Therapeutic Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Therapeutic Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Therapeutic Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Therapeutic Vaccines Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES THERAPEUTIC VACCINES MARKET FORECAST (2017-2022)

11.1 United States Therapeutic Vaccines Sales, Revenue Forecast (2017-2022)
11.2 United States Therapeutic Vaccines Sales Forecast by Type (2017-2022)
11.3 United States Therapeutic Vaccines Sales Forecast by Application (2017-2022)
11.4 Therapeutic Vaccines Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Therapeutic Vaccines
Table Classification of Therapeutic Vaccines
Figure United States Sales Market Share of Therapeutic Vaccines by Type in 2015
Table Application of Therapeutic Vaccines
Figure United States Sales Market Share of Therapeutic Vaccines by Application in 2015
Figure United States Therapeutic Vaccines Sales and Growth Rate (2012-2022)
Figure United States Therapeutic Vaccines Revenue and Growth Rate (2012-2022)
Table United States Therapeutic Vaccines Sales of Key Manufacturers (2015 and 2016)
Table United States Therapeutic Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Therapeutic Vaccines Sales Share by Manufacturers
Figure 2016 Therapeutic Vaccines Sales Share by Manufacturers
Table United States Therapeutic Vaccines Revenue by Manufacturers (2015 and 2016)
Table United States Therapeutic Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Therapeutic Vaccines Revenue Share by Manufacturers
Table 2016 United States Therapeutic Vaccines Revenue Share by Manufacturers
Table United States Market Therapeutic Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Therapeutic Vaccines Average Price of Key Manufacturers in 2015
Figure Therapeutic Vaccines Market Share of Top 3 Manufacturers
Figure Therapeutic Vaccines Market Share of Top 5 Manufacturers
Table United States Therapeutic Vaccines Sales by States (2012-2017)
Table United States Therapeutic Vaccines Sales Share by States (2012-2017)
Figure United States Therapeutic Vaccines Sales Market Share by States in 2015
Table United States Therapeutic Vaccines Revenue and Market Share by States (2012-2017)
Table United States Therapeutic Vaccines Revenue Share by States (2012-2017)
Figure Revenue Market Share of Therapeutic Vaccines by States (2012-2017)
Table United States Therapeutic Vaccines Price by States (2012-2017)
Table United States Therapeutic Vaccines Sales by Type (2012-2017)
Table United States Therapeutic Vaccines Sales Share by Type (2012-2017)
Figure United States Therapeutic Vaccines Sales Market Share by Type in 2015
Table United States Therapeutic Vaccines Revenue and Market Share by Type (2012-2017)
Table United States Therapeutic Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Therapeutic Vaccines by Type (2012-2017)
Table United States Therapeutic Vaccines Price by Type (2012-2017)
Figure United States Therapeutic Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Therapeutic Vaccines Sales by Application (2012-2017)
Table United States Therapeutic Vaccines Sales Market Share by Application (2012-2017)
Figure United States Therapeutic Vaccines Sales Market Share by Application in 2015
Table United States Therapeutic Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Therapeutic Vaccines Sales Growth Rate by Application (2012-2017)
Table Northwest Biotherapeutics Basic Information List
Table Northwest Biotherapeutics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Northwest Biotherapeutics Therapeutic Vaccines Sales Market Share (2012-2017)
Table Antigenics Basic Information List
Table Antigenics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Antigenics Therapeutic Vaccines Sales Market Share (2012-2017)
Table Vaccinogen? Basic Information List
Table Vaccinogen? Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Vaccinogen? Therapeutic Vaccines Sales Market Share (2012-2017)
Table CIMAB S.A. Basic Information List
Table CIMAB S.A. Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table CIMAB S.A. Therapeutic Vaccines Sales Market Share (2012-2017)
Table Dendreon Basic Information List
Table Dendreon Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Dendreon Therapeutic Vaccines Sales Market Share (2012-2017)
Table Corixa Basic Information List
Table Corixa Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table Corixa Therapeutic Vaccines Sales Market Share (2012-2017)
Table AVAX Basic Information List
Table AVAX Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
Table AVAX Therapeutic Vaccines Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Vaccines
Figure Manufacturing Process Analysis of Therapeutic Vaccines
Figure Therapeutic Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Vaccines Major Manufacturers in 2015
Table Major Buyers of Therapeutic Vaccines
Table Distributors/Traders List
Figure United States Therapeutic Vaccines Production and Growth Rate Forecast (2017-2022)
Figure United States Therapeutic Vaccines Revenue and Growth Rate Forecast (2017-2022)
Table United States Therapeutic Vaccines Production Forecast by Type (2017-2022)
Table United States Therapeutic Vaccines Consumption Forecast by Application (2017-2022)
Table United States Therapeutic Vaccines Sales Forecast by States (2017-2022)
Table United States Therapeutic Vaccines Sales Share Forecast by States (2017-2022)